Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.050
+0.270 (7.14%)
At close: Jul 2, 2025, 4:00 PM
4.090
+0.040 (0.99%)
After-hours: Jul 2, 2025, 7:59 PM EDT
Organogenesis Holdings Employees
Organogenesis Holdings had 869 employees as of December 31, 2024. The number of employees increased by 7 or 0.81% compared to the previous year.
Employees
869
Change (1Y)
7
Growth (1Y)
0.81%
Revenue / Employee
$527,917
Profits / Employee
-$23,507
Market Cap
513.76M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ORGO News
- 23 days ago - Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha
- 7 weeks ago - Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - GlobeNewsWire
- 3 months ago - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 4 months ago - Organogenesis Holdings Inc. (ORGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire